Invention Grant
- Patent Title: Sustained release formulations of nalbuphine
-
Application No.: US16198143Application Date: 2018-11-21
-
Publication No.: US10406106B2Publication Date: 2019-09-10
- Inventor: Anand R. Baichwal , Philip A. Goliber , Anthony E. Carpanzano , Thomas Sciascia , Donald Diehl , Brian Vogler , David Verbel , Stanley Au
- Applicant: ENDO PHARMACEUTICALS INC.
- Applicant Address: US PA Malvern
- Assignee: ENDO PHARMACEUTICALS INC.
- Current Assignee: ENDO PHARMACEUTICALS INC.
- Current Assignee Address: US PA Malvern
- Agency: Davidson, Davidson & Kappel, LLC
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/20 ; A61K9/24 ; A61K31/485 ; A61K9/28
Abstract:
Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
Public/Granted literature
- US20190117576A1 SUSTAINED RELEASE FORMULATIONS OF NALBUPHINE Public/Granted day:2019-04-25
Information query
